Search

Search Constraints

You searched for: Author/Creator Fassi, Daniel El

Search Results

2. Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy. Issue 13 (10th November 2019)

3. Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis. (22nd June 2018)

4. The value of next‐generation sequencing in routine diagnostics and management of patients with cytopenia. (10th February 2022)